Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression
- PMID: 23293563
- PMCID: PMC3533208
Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression
Abstract
Treatment regimens for Crohn's disease and ulcerative colitis increase susceptibility to infections, many of which can be prevented by vaccinations. Increased awareness concerning vaccine-preventable diseases has led to several studies investigating the immunologic responses to vaccines in immunosuppressed patients with inflammatory bowel disease. This review provides an overview of the evidence-based rationale for currently accepted recommendations regarding the use of both inactivated and live vaccines in this unique population.
Keywords: Inflammatory bowel disease; immunization; infection; pertussis; pneumococcal vaccine; vaccination.
References
-
- Melmed G, Ippoliti A, Papadakis K, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006;101:1834–1840. - PubMed
-
- Bernal I, Domenech E, Garcia-Planella E, et al. Opportunistic infections in patients with inflammatory bowel disease undergoing immunosuppressive therapy. Gastroenterol Hepatol. 2003;26:19–22. - PubMed
-
- Toruner M, Loftus E, Jr, Harmsen W, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134:929–936. - PubMed
-
- Viget N, Vernier-Massouille G, Salmon-Ceron D, et al. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut. 2008;57:549–558. - PubMed
LinkOut - more resources
Full Text Sources